Healthcare analyst at UBS
Appears in 1 story
Buy rating on Telix, A$22.00 target
Telix Pharmaceuticals, an Australian maker of cancer imaging and treatment agents, agreed on September 21 to buy German isotope producer ITM Isotope Technologies Munich. The deal is worth up to $2.35 billion all-in, with $1.65 billion paid upfront, most of it in Telix shares.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
